REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 167 filers reported holding REGENXBIO INC in Q3 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $595,934 | -35.3% | 36,205 | -21.4% | 0.00% | – |
| Q2 2023 | $920,499 | +6.5% | 46,048 | +0.7% | 0.00% | – |
| Q1 2023 | $864,660 | +120.4% | 45,725 | +164.3% | 0.00% | – |
| Q4 2022 | $392,388 | -41.0% | 17,301 | -31.2% | 0.00% | – |
| Q3 2022 | $665,000 | +4.6% | 25,138 | -2.3% | 0.00% | – |
| Q2 2022 | $636,000 | -57.3% | 25,737 | -42.6% | 0.00% | – |
| Q1 2022 | $1,490,000 | -41.2% | 44,876 | -42.1% | 0.00% | -100.0% |
| Q4 2021 | $2,535,000 | -22.9% | 77,547 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $3,286,000 | +10.2% | 78,386 | +2.2% | 0.00% | 0.0% |
| Q2 2021 | $2,981,000 | +23.4% | 76,735 | +8.4% | 0.00% | 0.0% |
| Q1 2021 | $2,415,000 | +25.7% | 70,803 | +67.2% | 0.00% | – |
| Q4 2020 | $1,921,000 | +98.7% | 42,350 | +20.5% | 0.00% | – |
| Q3 2020 | $967,000 | -39.2% | 35,149 | -18.6% | 0.00% | – |
| Q2 2020 | $1,590,000 | +16.5% | 43,184 | +2.5% | 0.00% | – |
| Q1 2020 | $1,365,000 | -62.3% | 42,146 | -52.3% | 0.00% | -100.0% |
| Q4 2019 | $3,620,000 | +51.6% | 88,348 | +31.7% | 0.00% | 0.0% |
| Q3 2019 | $2,388,000 | -34.0% | 67,084 | -4.7% | 0.00% | 0.0% |
| Q2 2019 | $3,616,000 | -17.8% | 70,380 | -8.3% | 0.00% | 0.0% |
| Q1 2019 | $4,401,000 | +56.0% | 76,785 | +14.2% | 0.00% | 0.0% |
| Q4 2018 | $2,821,000 | +18.7% | 67,260 | +113.7% | 0.00% | 0.0% |
| Q3 2018 | $2,377,000 | -7.1% | 31,471 | -11.7% | 0.00% | 0.0% |
| Q2 2018 | $2,558,000 | +154.3% | 35,653 | +5.8% | 0.00% | – |
| Q1 2018 | $1,006,000 | -14.5% | 33,699 | -4.7% | 0.00% | – |
| Q4 2017 | $1,176,000 | -19.7% | 35,356 | -20.5% | 0.00% | – |
| Q3 2017 | $1,465,000 | +357.8% | 44,473 | +174.4% | 0.00% | – |
| Q2 2017 | $320,000 | +3.6% | 16,209 | +1.1% | 0.00% | – |
| Q1 2017 | $309,000 | +4.0% | 16,034 | 0.0% | 0.00% | – |
| Q4 2016 | $297,000 | +116.8% | 16,034 | +64.6% | 0.00% | – |
| Q3 2016 | $137,000 | +705.9% | 9,744 | +368.9% | 0.00% | – |
| Q2 2016 | $17,000 | -22.7% | 2,078 | -7.0% | 0.00% | – |
| Q1 2016 | $22,000 | -35.3% | 2,235 | +7.6% | 0.00% | – |
| Q4 2015 | $34,000 | – | 2,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |